XNAS: LYEL
Lyell Immunopharma Inc Live Stock Price Today, Share Analysis and Chart
about
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...
Read More
19.02
-0.22
(-1.14%)
37,594
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Lyell Immunopharma Inc is on 20 May 2026 for the purpose of 2026 Stifel Virtual Targeted Oncology Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Lyell Immunopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..